Insufficient scRNA-seq data for expression of NUDT18 at single-cell level.
Insufficient scRNA-seq data for expression of NUDT18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 655.92 | 328 / 328 | 100% | 19.42 | 178 / 178 |
thymus | 100% | 656.28 | 653 / 653 | 100% | 25.80 | 604 / 605 |
prostate | 100% | 594.66 | 245 / 245 | 99% | 19.67 | 499 / 502 |
kidney | 100% | 441.09 | 89 / 89 | 99% | 19.51 | 895 / 901 |
intestine | 100% | 407.81 | 965 / 966 | 99% | 15.22 | 520 / 527 |
lung | 99% | 473.59 | 574 / 578 | 99% | 16.36 | 1139 / 1155 |
stomach | 100% | 469.37 | 359 / 359 | 98% | 12.84 | 280 / 286 |
esophagus | 100% | 383.41 | 1439 / 1445 | 98% | 11.54 | 179 / 183 |
skin | 100% | 513.81 | 1807 / 1809 | 97% | 16.35 | 460 / 472 |
breast | 100% | 521.15 | 459 / 459 | 97% | 20.44 | 1087 / 1118 |
brain | 98% | 445.67 | 2584 / 2642 | 99% | 12.63 | 699 / 705 |
bladder | 100% | 411.19 | 21 / 21 | 97% | 16.36 | 487 / 504 |
adrenal gland | 99% | 444.67 | 255 / 258 | 97% | 15.79 | 224 / 230 |
uterus | 99% | 346.44 | 168 / 170 | 97% | 15.98 | 443 / 459 |
liver | 98% | 213.70 | 222 / 226 | 84% | 9.50 | 340 / 406 |
ovary | 86% | 157.23 | 155 / 180 | 88% | 9.06 | 380 / 430 |
adipose | 100% | 471.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 34.39 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.75 | 29 / 29 |
spleen | 100% | 743.75 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.95 | 1 / 1 |
blood vessel | 100% | 440.27 | 1329 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 710.54 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 221.64 | 810 / 861 | 0% | 0 | 0 / 0 |
muscle | 51% | 78.48 | 410 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046057 | Biological process | dADP catabolic process |
GO_0046712 | Biological process | GDP catabolic process |
GO_0046067 | Biological process | dGDP catabolic process |
GO_0055086 | Biological process | nucleobase-containing small molecule metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0044716 | Molecular function | 8-oxo-GDP phosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0044715 | Molecular function | 8-oxo-dGDP phosphatase activity |
GO_0044717 | Molecular function | 8-hydroxy-dADP phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NUDT18 |
Protein name | Nudix hydrolase 18 8-oxo-dGDP phosphatase NUDT18 (EC 3.6.1.58) (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18) (Nudix motif 18) |
Synonyms | MTH3 |
Description | FUNCTION: Mediates the hydrolysis of oxidized nucleoside diphosphate derivatives. Hydrolyzes 8-oxo-7,8-dihydroguanine (8-oxo-Gua)-containing deoxyribo- and ribonucleoside diphosphates to the monophosphates. Hydrolyzes 8-oxo-dGDP and 8-oxo-GDP with the same efficiencies. Hydrolyzes also 8-OH-dADP and 2-OH-dADP. Exhibited no or minimal hydrolysis activity against 8-oxo-dGTP, 8-oxo-GTP, dGTP, GTP, dGDP and GDP. Probably removes oxidized guanine nucleotides from both the DNA and RNA precursor pools. . |
Accessions | Q6ZVK8 A0A087WW30 ENST00000611621.2 [Q6ZVK8-1] ENST00000613958.1 |